help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanni, L. A.
Right arrow Articles by Hunt, N. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanni, L. A.
Right arrow Articles by Hunt, N. H.

American Journal of Pathology, Vol 152, 611-619, Copyright © 1998 by American Society for Investigative Pathology


REGULAR ARTICLES

Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria

LA Sanni, SR Thomas, BN Tattam, DE Moore, G Chaudhri, R Stocker and NH Hunt
Department of Pathology, University of Sydney, New South Wales, Australia.

The pathogenesis of human cerebral malaria (CM) remains unresolved. In the most widely used murine model of CM, the presence of T lymphocytes and/or interferon (IFN)-gamma is a prerequisite. IFN-gamma is the key inducer of indoleamine 2,3-dioxygenase (IDO), which is the catalyst of the first, and rate-limiting, step in the metabolism of tryptophan (Trp) along the kynurenine (Kyn) pathway. Quinolinic acid (QA), a product of this pathway, is a neuro-excitotoxin, like glutamic acid (Glu) and aspartic acid (Asp). Kynurenic acid (KA), also produced from the Kyn pathway, antagonizes the neuro-excitotoxic effects of QA, Glu, and Asp. We therefore examined the possible roles of IDO, metabolites of the Kyn pathway, Glu, and Asp in the pathogenesis of fatal murine CM. Plasmodium berghei ANKA infection was studied on days 6 and 7 post- inoculation (p.i.), at which time the mice exhibited cerebral symptoms such as convulsions, ataxia, coma, and a positive Wooly/White sign and died within 24 hours. A model for noncerebral malaria (NCM), P. berghei K173 infection, was also studied on days 6 and 7 and 13 to 17 p.i. to examine whether any changes were a general response to malaria infection. Biochemical analyses were done by high-pressure liquid chromatography and gas chromatography/mass spectrometry/mass spectrometry (GC/MS/MS). IDO activity was low or absent in the brains of uninfected mice and NCM mice (days 6 and 7 p.i.) and was induced strongly in the brains of fatal murine CM mice (days 6 and 7 p.i.) and NCM animals (days 13 to 17 p.i.). This induction was inhibited greatly by administration of dexamethasone, a treatment that also prevented CM symptoms and death. Furthermore, IDO induction was absent in IFN-gamma gene knockout mice, which were also resistant to CM. Brain concentrations of Kyn, 3-hydroxykynurenine, and the neuro-excitotoxin QA were significantly increased in both CM mice on days 6 and 7 p.i. and NCM mice on days 13 to 17 p.i., whereas an increase in the ratio of brain QA to KA occurred only in the CM mice at the time they were exhibiting cerebral symptoms. Brain concentrations of Glu and Asp were significantly decreased in CM and NCM mice (days 13 to 17 p.i.). The results imply that neuro-excitation induced by QA may contribute to the convulsions and neuro-excitatory signs observed in CM.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. R. Thomas, A. C. Terentis, H. Cai, O. Takikawa, A. Levina, P. A. Lay, M. Freewan, and R. Stocker
Post-translational Regulation of Human Indoleamine 2,3-Dioxygenase Activity by Nitric Oxide
J. Biol. Chem., August 17, 2007; 282(33): 23778 - 23787.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Aldinucci, G. Gerlini, S. Fossati, G. Cipriani, C. Ballerini, T. Biagioli, N. Pimpinelli, L. Borgognoni, L. Massacesi, F. Moroni, et al.
A Key Role for Poly(ADP-Ribose) Polymerase-1 Activity during Human Dendritic Cell Maturation
J. Immunol., July 1, 2007; 179(1): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. J. Mitchell, A. M. Hansen, L. Hee, H. J. Ball, S. M. Potter, J. C. Walker, and N. H. Hunt
Early Cytokine Production Is Associated with Protection from Murine Cerebral Malaria
Infect. Immun., September 1, 2005; 73(9): 5645 - 5653.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
S. Russo, I. P. Kema, E. B. Haagsma, J. C. Boon, P. H.B. Willemse, J. A. den Boer, E. G.E. de Vries, and J. Korf
Irritability Rather Than Depression During Interferon Treatment Is Linked to Increased Tryptophan Catabolism
Psychosom Med, September 1, 2005; 67(5): 773 - 777.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. J. Clark, G. M. Mackay, G. A. Smythe, S. Bustamante, T. W. Stone, and R. S. Phillips
Prolonged Survival of a Murine Model of Cerebral Malaria by Kynurenine Pathway Inhibition
Infect. Immun., August 1, 2005; 73(8): 5249 - 5251.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Bozza, F. Fallarino, L. Pitzurra, T. Zelante, C. Montagnoli, S. Bellocchio, P. Mosci, C. Vacca, P. Puccetti, and L. Romani
A Crucial Role for Tryptophan Catabolism at the Host/Candida albicans Interface
J. Immunol., March 1, 2005; 174(5): 2910 - 2918.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. A. Sanni, W. Jarra, C. Li, and J. Langhorne
Cerebral Edema and Cerebral Hemorrhages in Interleukin-10-Deficient Mice Infected with Plasmodium chabaudi
Infect. Immun., May 1, 2004; 72(5): 3054 - 3058.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. RAE, J. A. MCQUILLAN, S. B. PAREKH, W. A. BUBB, S. WEISER, V. J. BALCAR, A. M. HANSEN, H. J. BALL, and N. H. HUNT
Brain gene expression, metabolism, and bioenergetics: interrelationships in murine models of cerebral and noncerebral malaria
FASEB J, March 1, 2004; 18(3): 499 - 510.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. K. Littlejohn, O. Takikawa, R. J. W. Truscott, and M. J. Walker
Asp274 and His346 Are Essential for Heme Binding and Catalytic Function of Human Indoleamine 2,3-Dioxygenase
J. Biol. Chem., August 8, 2003; 278(32): 29525 - 29531.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
S. Russo, I. P. Kema, M. R. Fokkema, J. C. Boon, P. H. B. Willemse, E. G. E. de Vries, J. A. den Boer, and J. Korf
Tryptophan as a Link between Psychopathology and Somatic States
Psychosom Med, July 1, 2003; 65(4): 665 - 671.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J.-L. Perfettini, T. Darville, A. Dautry-Varsat, R. G. Rank, and D. M. Ojcius
Inhibition of Apoptosis by Gamma Interferon in Cells and Mice Infected with Chlamydia muridarum (the Mouse Pneumonitis Strain of Chlamydia trachomatis)
Infect. Immun., May 1, 2002; 70(5): 2559 - 2565.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Hayashi, S. P. Rao, K. Takabayashi, J. H. Van Uden, R. S. Kornbluth, S. M. Baird, M. W. Taylor, D. A. Carson, A. Catanzaro, and E. Raz
Enhancement of Innate Immunity against Mycobacterium avium Infection by Immunostimulatory DNA Is Mediated by Indoleamine 2,3-Dioxygenase
Infect. Immun., October 1, 2001; 69(10): 6156 - 6164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. A. Sanni, C. Rae, A. Maitland, R. Stocker, and N. H. Hunt
Is Ischemia Involved in the Pathogenesis of Murine Cerebral Malaria?
Am. J. Pathol., September 1, 2001; 159(3): 1105 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. Thomas, H. Salahifar, R. Mashima, N. H. Hunt, D. R. Richardson, and R. Stocker
Antioxidants Inhibit Indoleamine 2,3-Dioxygenase in IFN-{{gamma}}-Activated Human Macrophages: Posttranslational Regulation by Pyrrolidine Dithiocarbamate
J. Immunol., May 15, 2001; 166(10): 6332 - 6340.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Chiarugi, P. D. Sbarba, A. Paccagnini, S. Donnini, S. Filippi, and F. Moroni
Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-{gamma}-activated macrophages
J. Leukoc. Biol., August 1, 2000; 68(2): 260 - 266.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
W. Daubener, C. Hucke, K. Seidel, U. Hadding, and C. R. MacKenzie
Interleukin-1 Inhibits Gamma Interferon-Induced Bacteriostasis in Human Uroepithelial Cells
Infect. Immun., November 1, 1999; 67(11): 5615 - 5620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.